Unique molecules represent an emerging frontier in drug discovery. These particular small chains of protein acids offer unprecedented promise for engaging previously targets involved in multiple conditions. Initial investigations demonstrate they can provide selective binding and show favorable ADME properties, paving doors to novel treatments. Con